Table 2.
SOC (n = 14) | CCP (n = 17) | Effect size | p-value | |
---|---|---|---|---|
Time of oxygen treatment, dayse | 7 (5–9)a | 11 (6–15)a | −4c | 0.43 |
Length of stay, days | 8 (6–10)a | 13 (7–16)a | −5c | 0.21 |
Progression to HFNCf | 4/13 (31)b | 4/16 (25)b | 0.75 (0.18–3.18)d | > 0.99 |
Progression to ventilator treatment | 1 (7)b | 0b | 0 (0–7.41)d | 0.45 |
Death | 3 (21)b | 2 (12)b | 0.49 (0.08–2.79)d | 0.64 |
aMedian (IQR). bNumbers (%). cMedian difference. dOdds ratio (CI).eFor patients surviving 28-days. fOne patient in each group with ongoing HFNC on inclusion was excluded from the analysis